145 related articles for article (PubMed ID: 32875516)
1. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape.
Ferretti F; De Zan V; Gerevini S; Turrini F; Boeri E; Gianotti N; Hasson H; Lazzarin A; Cinque P
Curr HIV/AIDS Rep; 2020 Oct; 17(5):522-528. PubMed ID: 32875516
[TBL] [Abstract][Full Text] [Related]
2. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.
Mukerji SS; Misra V; Lorenz D; Cervantes-Arslanian AM; Lyons J; Chalkias S; Wurcel A; Burke D; Venna N; Morgello S; Koralnik IJ; Gabuzda D
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):246-255. PubMed ID: 28328546
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
Edén A; Fuchs D; Hagberg L; Nilsson S; Spudich S; Svennerholm B; Price RW; Gisslén M
J Infect Dis; 2010 Dec; 202(12):1819-25. PubMed ID: 21050119
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
Ferretti F; Gisslen M; Cinque P; Price RW
Curr HIV/AIDS Rep; 2015 Jun; 12(2):280-8. PubMed ID: 25860317
[TBL] [Abstract][Full Text] [Related]
5. HIV encephalitis in a patient on antiretroviral therapy: a case report.
Hlebowicz M; Parczewski M; Jakubowski P
Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
[TBL] [Abstract][Full Text] [Related]
6. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580
[TBL] [Abstract][Full Text] [Related]
7. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
[TBL] [Abstract][Full Text] [Related]
8. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?
Joseph SB; Trunfio M; Kincer LP; Calcagno A; Price RW
AIDS; 2019 Dec; 33 Suppl 2():S171-S179. PubMed ID: 31790378
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic cerebrospinal fluid escape.
Mastrangelo A; Turrini F; de Zan V; Caccia R; Gerevini S; Cinque P
AIDS; 2019 Dec; 33 Suppl 2():S159-S169. PubMed ID: 31789816
[TBL] [Abstract][Full Text] [Related]
10. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
[TBL] [Abstract][Full Text] [Related]
11. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.
Trunfio M; Joseph SB; Ghisetti V; Romito A; Martini C; Cusato J; Audagnotto S; Pesci Kincer L; Ferrara M; Sala A; Imperiale D; Di Perri G; Calcagno A
J Neurovirol; 2018 Feb; 24(1):132-136. PubMed ID: 29243133
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid HIV RNA in persons living with HIV.
Di Carlofelice M; Everitt A; Muir D; Winston A
HIV Med; 2018 May; 19(5):365-368. PubMed ID: 29368400
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
16. Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape.
Chan TY; Marta M; Rackstraw S
HIV Med; 2023 Nov; 24(11):1158-1163. PubMed ID: 37487714
[TBL] [Abstract][Full Text] [Related]
17. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
18. A rare case of HIV CNS escape in a patient previously considered a viral controller.
Magid-Bernstein J; Guo CY; Chow FC; Thakur KT
Int J STD AIDS; 2020 Jun; 31(7):694-698. PubMed ID: 32538333
[TBL] [Abstract][Full Text] [Related]
19. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
[TBL] [Abstract][Full Text] [Related]
20. Learning from cerebrospinal fluid drug-resistant HIV escape-associated encephalitis: a case report.
Kang J; Wang Z; Zhou Y; Wang W; Wen Y
Virol J; 2023 Dec; 20(1):292. PubMed ID: 38072961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
